Skip directly to search Skip directly to A to Z list Skip directly to site content
CDC Home

Volume 16, Number 9—September 2010

Dispatch

KI and WU Polyomaviruses and CD4+ Cell Counts in HIV-1–infected Patients, Italy

Muhammed Babakir-Mina, Massimo Ciccozzi, Francesca Farchi, Massimiliano Bergallo, Rossana Cavallo, Gaspare Adorno, Carlo Federico Perno, and Marco CiottiComments to Author 
Author affiliations: Author affiliations: Foundation University Hospital Tor Vergata, Rome, Italy (M. Babakir-Mina, G. Adorno, C.F. Perno, M. Ciotti); Istituto Superiore di Sanita’, Rome (M. Ciccozzi, F. Farchi); University of Turin, Turin, Italy (M. Bergallo, R. Cavallo)

Main Article

Table 2

Treatment regimens for 11 HIV-1–positive patients co-infected with KI or WU polyomavirus, Italy, 2004–2009*

Patient no. KIPyV WUPyV HAART
1 + None
2 + None
3 + None
4 + NRTI: FTC, TDF; PI: ATV, RTV
5 + NNRTI: EFV; NRTI: 3TC, TDF
6 + NNRTI: NVP; NRTI: 3TC, AZT
7 + NRTI: 3TC, AZT; PI: ATV, RTV
8 + NNRTI: NVP; NRTI: ABC, TDF
9 + None
10 + NNRTI: EFV; NRTI: 3TC, D4T
11 + None

*KIPyV, KI polyomavirus; WUPyV, WU polyomavirus; HAART, highly active antiretroviral therapy; NRTI, nucleoside reverse transcriptase inhibitor; FTC, emtricitabine; TDF, tenofovir; PI, protease inhibitor; ATV, atazanavir; RTV, ritonavir; NNRTI, nonnucleoside reverse transcriptase inhibitor; EFV, Efavirenz; 3TC, lamivudine; NVP, nevirapine; AZT, azidothymidine; ABC, D4T, stavudine.

Main Article

Top of Page

USA.gov: The U.S. Government's Official Web PortalDepartment of Health and Human Services
Centers for Disease Control and Prevention   1600 Clifton Rd. Atlanta, GA 30333, USA
800-CDC-INFO (800-232-4636) TTY: (888) 232-6348 - Contact CDC–INFO